In addition to subclinical inflammation, the presence of auto-antibodies (anti-citrullinated peptide antibody (ACPA) and rheumatoid factor (RF)) is associated with the development of clinical arthritis [16]. This evidence concerns the gene PRTN3 and arthritic joint disease.